{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:21:07Z","timestamp":1788200467443,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ctim.2017.07.010","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T13:01:42Z","timestamp":1501074102000},"page":"46-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Total glucosides of paeony for rheumatoid arthritis: A systematic review of randomized controlled trials"],"prefix":"10.1016","volume":"34","author":[{"given":"Jing","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di-Er","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Wen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2017.07.010_bib0005","series-title":"Rheumatoid Arthritis","author":"American College of Rheumatology","year":"2013"},{"issue":"7","key":"10.1016\/j.ctim.2017.07.010_bib0010","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ctim.2017.07.010_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/ard.2008.101378","article-title":"Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and\/or leflunomide","volume":"69","author":"Curtis","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ctim.2017.07.010_bib0020","article-title":"Rituximab for rheumatoid arthritis","volume":"1","author":"Lopez-Olivo","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ctim.2017.07.010_bib0025","article-title":"Etanercept for the treatment of rheumatoid arthritis","volume":"5","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"9990","key":"10.1016\/j.ctim.2017.07.010_bib0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)61704-9","article-title":"Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"386","author":"Singh","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctim.2017.07.010_bib0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rdc.2010.11.004","article-title":"Herbal medicine for of rheumatic diseases","volume":"37","author":"Ernst","year":"2011","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.ctim.2017.07.010_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.intimp.2012.06.001","article-title":"Mechanisms involved in the therapeutic effects of Paeonia lactiflora Pallas in rheumatoid arthritis","volume":"14","author":"Zhang","year":"2012","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.ctim.2017.07.010_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jep.2008.09.028","article-title":"Effects and mechanisms of total glucosides of paeony on synoviocytes activities in rat collagen-induced arthritis","volume":"121","author":"Chang","year":"2009","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.ctim.2017.07.010_bib0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clim.2012.02.002","article-title":"Total glucosides of paeony induces regulatory CD4(+)CD25(+) T cells by increasing Foxp3 demethylation in lupus CD4(+) T cells","volume":"143","author":"Zhao","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ctim.2017.07.010_bib0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fphar.2011.00010","article-title":"Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall., a traditional Chinese herbal medicine","volume":"2","author":"He","year":"2011","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.ctim.2017.07.010_bib0060","first-page":"487","article-title":"A clinical study of total glucosides of paeony in the treatment of rheumatoid arthritis: a multi-center trial","volume":"9","author":"Min","year":"2005","journal-title":"Chin J Rheumatol"},{"issue":"1","key":"10.1016\/j.ctim.2017.07.010_bib0065","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.intimp.2015.08.008","article-title":"Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis","volume":"28","author":"Xiang","year":"2015","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.ctim.2017.07.010_bib0070","first-page":"653","article-title":"Meta-analysis of total glucosides of paeony combined with methotrexate in treatment for rheumatoid arthritis","volume":"19","author":"Shang","year":"2010","journal-title":"Mod J Integr Trad Chin West Med"},{"issue":"4","key":"10.1016\/j.ctim.2017.07.010_bib0075","first-page":"1115","article-title":"Meta-Analysis of total glucosides paeony combined with methorexate in treating rheumatoid arthritis","volume":"27","author":"Li","year":"2012","journal-title":"China J Trad Chin Med Pharmacy"},{"issue":"39","key":"10.1016\/j.ctim.2017.07.010_bib0080","first-page":"3731","article-title":"Meta-analysis of the efficacy and safety of total glucosides of paeony combined with immunosuppressant in the treatment of rheumatoid arthritis","volume":"21","author":"Zhong","year":"2010","journal-title":"China Pharmacy"},{"issue":"3","key":"10.1016\/j.ctim.2017.07.010_bib0085","first-page":"83","article-title":"Efficacy and safety of Total Glucosides of Paeony for rheumatoid arthritis","volume":"34","author":"Guo","year":"2013","journal-title":"J Jinggangshan Univ (Nat Sci)"},{"key":"10.1016\/j.ctim.2017.07.010_bib0090","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ctim.2017.07.010_bib0095","doi-asserted-by":"crossref","first-page":"e010116","DOI":"10.1136\/bmjopen-2015-010116","article-title":"Total glucosides of paeony for rheumatoid arthritis: a protocol for a systematic review","volume":"6","author":"Luo","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.ctim.2017.07.010_bib0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ctim.2017.07.010_bib0105","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an american college of Rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ctim.2017.07.010_bib0110","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology: preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ctim.2017.07.010_bib0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ctim.2017.07.010_bib0120","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/rheumatology\/keh297","article-title":"Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria","volume":"43","author":"Fransen","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ctim.2017.07.010_bib0125","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011"},{"key":"10.1016\/j.ctim.2017.07.010_bib0130","series-title":"GRADE Handbook for Grading Quality of Evidence and Strength of Recommendation. Version 3.2 [updated March 2009]","author":"Sch\u00fcnemann","year":"2009"},{"issue":"16","key":"10.1016\/j.ctim.2017.07.010_bib0135","first-page":"4","article-title":"Effects observation of different treatment program in rheumatoid arthritis","volume":"23","author":"Lin","year":"2016","journal-title":"China Mod Med"},{"issue":"7","key":"10.1016\/j.ctim.2017.07.010_bib0140","first-page":"597","article-title":"Efficacy of total glucosides of paeonia on blood lipid in patients with rheumatoid arthritis","volume":"32","author":"Zhang","year":"2016","journal-title":"Chin J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ctim.2017.07.010_bib0145","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.intimp.2013.01.021","article-title":"Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis","volume":"15","author":"Chen","year":"2013","journal-title":"Int Immunopharmacol"},{"issue":"13","key":"10.1016\/j.ctim.2017.07.010_bib0150","first-page":"1644","article-title":"Effect of combination of total glucosides of paeonia and immunosuppressive on transaminase in treatment of rheumatoid arthritis","volume":"16","author":"Wang","year":"2012","journal-title":"Med Forum"},{"issue":"4","key":"10.1016\/j.ctim.2017.07.010_bib0155","first-page":"9","article-title":"Total glucosides of paeony in combination with leflunomide for the treatment of active rheumatoid arthritis","volume":"25","author":"Yu","year":"2010","journal-title":"Forum Trad Chin Med"},{"key":"10.1016\/j.ctim.2017.07.010_bib0160","series-title":"Methotrexate, Hydroxychloroquine and Total Glucosides of Paeony for Patients with Rheumatoid Arthritis","author":"Tian","year":"2008"},{"issue":"3","key":"10.1016\/j.ctim.2017.07.010_bib0165","first-page":"83","article-title":"Total glucosides of paeony in combination with methotrexate for the treatment of rheumatoid arthritis","volume":"34","author":"Liu","year":"2007","journal-title":"Central Plains Med J"},{"issue":"11","key":"10.1016\/j.ctim.2017.07.010_bib0170","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ctim.2017.07.010_bib0175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-144-5-200603070-00013","article-title":"Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement","volume":"144","author":"Gagnier","year":"2006","journal-title":"Ann Intern Med"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229917303837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229917303837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:06:58Z","timestamp":1760807218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229917303837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":35,"alternative-id":["S0965229917303837"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2017.07.010","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total glucosides of paeony for rheumatoid arthritis: A systematic review of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2017.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}